{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:12:27Z","timestamp":1770196347356,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,26]]},"DOI":"10.7759\/cureus.83051","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T05:56:23Z","timestamp":1745733383000},"source":"Crossref","is-referenced-by-count":1,"title":["Assessment of Serum Phosphate Levels in Chronic Kidney Disease Patients Across Different Stages of Kidney Disease"],"prefix":"10.7759","author":[{"given":"Arbab","family":"Muhammad Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moazzam","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waqar","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Liaqat Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khushhal Khan","family":"Nungyaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayat","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ayaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease - a systematic review and meta-analysis","volume":"11","author":"Hill NR","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, Hobbs FD. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016, 11:e0158765. 10.1371\/journal.pone.0158765","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha V","year":"2013","unstructured":"Jha V, Garcia-Garcia G, Iseki K, et al.. Chronic kidney disease: global dimension and perspectives. Lancet. 2013, 382:260-72. 10.1016\/S0140-6736(13)60687-X","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05040610","article-title":"Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease","volume":"6","author":"Moe SM","year":"2011","unstructured":"Moe SM, Zidehsarai MP, Chambers MA, et al.. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2011, 6:257-64. 10.2215\/CJN.05040610","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block GA","year":"2007","unstructured":"Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 2007, 71:438-41. 10.1038\/sj.ki.5002059","journal-title":"Kidney Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017070772","article-title":"Longitudinal FGF23 trajectories and mortality in patients with CKD","volume":"29","author":"Isakova T","year":"2018","unstructured":"Isakova T, Cai X, Lee J, et al.. Longitudinal FGF23 trajectories and mortality in patients with CKD. J Am Soc Nephrol. 2018, 29:579-90. 10.1681\/ASN.2017070772","journal-title":"J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian M","year":"2013","unstructured":"Afkarian M, Sachs MC, Kestenbaum B, Hirsch IB, Tuttle KR, Himmelfarb J, de Boer IH. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013, 24:302-8. 10.1681\/ASN.2012070718","journal-title":"J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/939613","article-title":"Association of serum phosphate and related factors in ESRD-related vascular calcification","volume":"2011","author":"Zheng CM","year":"2011","unstructured":"Zheng CM, Lu KC, Wu CC, Hsu YH, Lin YF. Association of serum phosphate and related factors in ESRD-related vascular calcification. Int J Nephrol. 2011, 2011:939613. 10.4061\/2011\/939613","journal-title":"Int J Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.05.020","article-title":"Treatment of iron deficiency anemia in CKD and end-stage kidney disease","volume":"6","author":"Guti\u00e9rrez OM","year":"2021","unstructured":"Guti\u00e9rrez OM. Treatment of iron deficiency anemia in CKD and end-stage kidney disease. Kidney Int Rep. 2021, 6:2261-9. 10.1016\/j.ekir.2021.05.020","journal-title":"Kidney Int Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin A","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007, 71:31-8. 10.1038\/sj.ki.5002009","journal-title":"Kidney Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1079622","article-title":"Novel iron-containing phosphate binders for treatment of hyperphosphatemia","volume":"16","author":"Schmid H","year":"2015","unstructured":"Schmid H, Lederer SR. Novel iron-containing phosphate binders for treatment of hyperphosphatemia. Expert Opin Pharmacother. 2015, 16:2179-91. 10.1517\/14656566.2015.1079622","journal-title":"Expert Opin Pharmacother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012070713","article-title":"Mineral metabolites and CKD progression in African Americans","volume":"24","author":"Scialla JJ","year":"2013","unstructured":"Scialla JJ, Astor BC, Isakova T, Xie H, Appel LJ, Wolf M. Mineral metabolites and CKD progression in African Americans. J Am Soc Nephrol. 2013, 24:125-35. 10.1681\/ASN.2012070713","journal-title":"J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum B","year":"2005","unstructured":"Kestenbaum B, Sampson JN, Rudser KD, et al.. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005, 16:520-8. 10.1681\/ASN.2004070602","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019060640","article-title":"Influence of mortality on estimating the risk of kidney failure in people with stage 4 CKD","volume":"30","author":"Ravani P","year":"2019","unstructured":"Ravani P, Fiocco M, Liu P, et al.. Influence of mortality on estimating the risk of kidney failure in people with stage 4 CKD. J Am Soc Nephrol. 2019, 30:2219-27. 10.1681\/ASN.2019060640","journal-title":"J Am Soc Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00390118","article-title":"Twenty-four-hour urine phosphorus as a biomarker of dietary phosphorus intake and absorption in CKD: a secondary analysis from a controlled diet balance study","volume":"13","author":"Stremke ER","year":"2018","unstructured":"Stremke ER, McCabe LD, McCabe GP, et al.. Twenty-four-hour urine phosphorus as a biomarker of dietary phosphorus intake and absorption in CKD: a secondary analysis from a controlled diet balance study. Clin J Am Soc Nephrol. 2018, 13:1002-12. 10.2215\/CJN.00390118","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","unstructured":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl (2011). 2017, 7.1-59. 10.1016\/j.kisu.2017.04.001","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006023.pub3","article-title":"Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"8","author":"Ruospo M","year":"2018","unstructured":"Ruospo M, Palmer SC, Natale P, Craig JC, Vecchio M, Elder GJ, Strippoli GF. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). Cochrane Database Syst Rev. 2018, 8:CD006023. 10.1002\/14651858.CD006023.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015020117","article-title":"Rationale and approaches to phosphate and fibroblast growth factor 23 reduction in CKD","volume":"26","author":"Isakova T","year":"2015","unstructured":"Isakova T, Ix JH, Sprague SM, et al.. Rationale and approaches to phosphate and fibroblast growth factor 23 reduction in CKD. J Am Soc Nephrol. 2015, 26:2328-39. 10.1681\/ASN.2015020117","journal-title":"J Am Soc Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008020141","article-title":"Serum phosphorus levels associate with coronary atherosclerosis in young adults","volume":"20","author":"Foley RN","year":"2009","unstructured":"Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol. 2009, 20:397-404. 10.1681\/ASN.2008020141","journal-title":"J Am Soc Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.03.022","article-title":"Dietary potassium intake and mortality in long-term hemodialysis patients","volume":"56","author":"Noori N","year":"2010","unstructured":"Noori N, Kalantar-Zadeh K, Kovesdy CP, Murali SB, Bross R, Nissenson AR, Kopple JD. Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kidney Dis. 2010, 56:338-47. 10.1053\/j.ajkd.2010.03.022","journal-title":"Am J Kidney Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab184","article-title":"Independent effects of secondary hyperparathyroidism and hyperphosphatemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort","volume":"37","author":"Bozic M","year":"2021","unstructured":"Bozic M, D\u00edaz-Tocados JM, Berm\u00fadez-L\u00f3pez M, et al.. Independent effects of secondary hyperparathyroidism and hyperphosphatemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort. Nephrol Dial Transplant. 2021, 37:663-72. 10.1093\/ndt\/gfab184","journal-title":"Nephrol Dial Transplant"},{"key":"ref21","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","unstructured":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl (2011). 2013, 3.1.","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.7870-21","article-title":"Association between serum inorganic phosphorus levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study","volume":"61","author":"Oda A","year":"2022","unstructured":"Oda A, Tanaka K, Saito H, et al.. Association between serum inorganic phosphorus levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study. Intern Med. 2022, 61:1653-62. 10.2169\/internalmedicine.7870-21","journal-title":"Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.07.022","article-title":"Longitudinal evolution of markers of mineral metabolism in patients with CKD: the chronic renal insufficiency cohort (CRIC) study","volume":"75","author":"Isakova T","year":"2020","unstructured":"Isakova T, Cai X, Lee J, et al.. Longitudinal evolution of markers of mineral metabolism in patients with CKD: the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 2020, 75:235-44. 10.1053\/j.ajkd.2019.07.022","journal-title":"Am J Kidney Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.21089\/njhs.94.0265","article-title":"Correlation of iPTH, serum calcium, and serum phosphorus with different stages of chronic kidney disease","volume":"9","author":"Jawaid MT","year":"2024","unstructured":"Jawaid MT, Jamil B, Syed AZ, Kulsoom K, Mehdi AWR, Alam E. Correlation of iPTH, serum calcium, and serum phosphorus with different stages of chronic kidney disease. Nat J Health Sci. 2024, 9:265-70. 10.21089\/njhs.94.0265","journal-title":"Nat J Health Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova T","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, et al.. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011, 79:1370-8. 10.1038\/ki.2011.47","journal-title":"Kidney Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer SC","year":"2011","unstructured":"Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA. 2011, 305:1119-27. 10.1001\/jama.2011.308","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtumed.2021.09.009","article-title":"Assessment of serum biochemical derangements and associated risk factors of chronic kidney disease","volume":"17","author":"Mehmood HR","year":"2022","unstructured":"Mehmood HR, Khan Z, Jahangir HM, Hussain A, Elahi A, Askari SM. Assessment of serum biochemical derangements and associated risk factors of chronic kidney disease. J Taibah Univ Med Sci. 2022, 17:376-83. 10.1016\/j.jtumed.2021.09.009","journal-title":"J Taibah Univ Med Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block GA","year":"2012","unstructured":"Block GA, Wheeler DC, Persky MS, et al.. Effects of phosphate binders in moderate CKD. J Am Soc Nephrol. 2012, 23:1407-15. 10.1681\/ASN.2012030223","journal-title":"J Am Soc Nephrol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.18203\/2394-6040.ijcmph20233838","article-title":"A comparative analysis of serum phosphorus levels and mineral metabolic markers in non-dialysis and dialysis chronic kidney disease patients: a cross-sectional study","volume":"11","author":"Pandit SK","year":"2023","unstructured":"Pandit SK, Vohra A, Mahali AK, Rajendran KP. A comparative analysis of serum phosphorus levels and mineral metabolic markers in non-dialysis and dialysis chronic kidney disease patients: a cross-sectional study. Int J Community Med Public Health. 2023, 11:10.18203\/2394-6040.ijcmph20233838","journal-title":"Int J Community Med Public Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/348727-assessment-of-serum-phosphate-levels-in-chronic-kidney-disease-patients-across-different-stages-of-kidney-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T05:56:24Z","timestamp":1745733384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/348727-assessment-of-serum-phosphate-levels-in-chronic-kidney-disease-patients-across-different-stages-of-kidney-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.83051","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,26]]}}}